ArticleScientific reports2021

Glycan reactive anti-HIV-1 antibodies bind the SARS-CoV-2 spike protein but do not block viral entry.

Dhiraj Mannar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.